A. Saborowski

机构：Medizinische Hochschule Hannover

发表论文 13 篇 · 总被引 49 次 · h-index 3

代表论文

• 53MO Nal-IRI and 5-FU/LV compared to 5-FU/LV in patients with cholangio- and gallbladder carcinoma previously treated with gemcitabine-based therapies (NALIRICC – AIO-HEP-0116) (2022 · Annals of Oncology · 被引 33)
• 52MO A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC) (2022 · Annals of Oncology · 被引 9)
• LBA51 IKF-035/ABC-HCC: A phase IIIb, randomized, multicenter, open-label trial of atezolizumab plus bevacizumab versus transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma (2025 · Annals of Oncology · 被引 4)
• 288P Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis (2024 · Annals of Oncology · 被引 2)
• 304P Clinical response to futibatinib in intrahepatic cholangiocarcinoma with acquired resistance to fibroblast growth factor receptor 2 inhibitors (2024 · Annals of Oncology · 被引 1)
• 355P BRCA I/II, PALB2 and non-core DNA damage repair-related alterations in biliary tract cancer: an international multicenter retrospective study to assess clinical, therapeutic and molecular implications (2026 · Annals of Oncology)